Axonics Inc AXNX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AXNX is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $58.06
- Day Range
- $57.40–58.53
- 52-Week Range
- $47.59–69.74
- Bid/Ask
- $58.41 / $58.72
- Market Cap
- $2.97 Bil
- Volume/Avg
- 52,397 / 559,247
Key Statistics
- Price/Earnings (Normalized)
- 2,738.29
- Price/Sales
- 8.27
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 610
- Website
- https://www.axonics.com
Valuation
|
Metric
|
AXNX
|
|---|---|
Price/Earnings (Normalized) | 2,738.29 |
Price/Book Value | 4.82 |
Price/Sales | 8.27 |
Price/Cash Flow | 46.29 |
Price/Earnings
AXNX
Financial Strength
|
Metric
|
AXNX
|
|---|---|
Quick Ratio | 11.06 |
Current Ratio | 13.36 |
Interest Coverage | — |
Quick Ratio
AXNX
Profitability
|
Metric
|
AXNX
|
|---|---|
Return on Assets (Normalized) | 6.28% |
Return on Equity (Normalized) | 7.06% |
Return on Invested Capital (Normalized) | 4.50% |
Return on Assets
AXNX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Mprffd | $182.6 Bil | |
SYK
| Stryker Corp | Qrdm | $110.5 Bil | |
MDT
| Medtronic PLC | Yqtt | $106.1 Bil | |
BSX
| Boston Scientific Corp | Brlfbvd | $80.2 Bil | |
DXCM
| DexCom Inc | Rzw | $45.1 Bil | |
EW
| Edwards Lifesciences Corp | Nvvwgy | $42.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Yrgn | $24.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Bnxmmq | $18.9 Bil | |
ALGN
| Align Technology Inc | Frlzcx | $16.8 Bil | |
PODD
| Insulet Corp | Vrggvns | $13.5 Bil |